Sherbrooke Park Advisers LLC Annexon, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 30,134 shares of ANNX stock, worth $83,169. This represents 0.05% of its overall portfolio holdings.
Number of Shares
30,134
Previous 43,031
29.97%
Holding current value
$83,169
Previous $255 Million
39.32%
% of portfolio
0.05%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
98.2MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$20.4 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$19.3 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.2 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$17.4 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$15.5 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $131M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...